Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyunji Ju

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cytokine|June 8, 2023
Engineered CD8Hanchae Cho, Inseong Jung, Hyunji Ju, et al.
Biomaterials|April 10, 2025
Engineered extracellular vesicles with surface FGF21 and enclosed miR-223 for treating metabolic dysfunction-associated steatohepatitisHanchae Cho, Hyunji Ju, Yongdeok Ahn, et al.
Nano Letters|July 15, 2025
T-Cell-Derived Extracellular Vesicles with an Antitransferrin Receptor Antibody for Multicancer TargetingHanchae Cho, Hyunji Ju, Sanghee Shin, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cytokine|June 8, 2023
Engineered CD8Hanchae Cho, Inseong Jung, Hyunji Ju, et al.
Biomaterials|April 10, 2025
Engineered extracellular vesicles with surface FGF21 and enclosed miR-223 for treating metabolic dysfunction-associated steatohepatitisHanchae Cho, Hyunji Ju, Yongdeok Ahn, et al.
Nano Letters|July 15, 2025
T-Cell-Derived Extracellular Vesicles with an Antitransferrin Receptor Antibody for Multicancer TargetingHanchae Cho, Hyunji Ju, Sanghee Shin, et al.
Pageof 1